Jianjun Cheng

23PUBLICATIONS
34CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 20, 2026
Pharmacokinetics-Driven Optimization of Immunotherapeutic Agents Targeting the Adenosine A2A Receptor (A2AR) and Histone Deacetylases (HDACs).

Wenzhong Yan, Mingshun Feng, Kexin Yang

|Oct 14, 2025
Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects.

Rongyan Li, Haohan Yan, Yujin Chen

|Nov 30, 2023
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.

Wenwen Duan, Dongmei Cao, Sheng Wang

|Oct 13, 2023
Design and Synthesis of Novel GPR139 Agonists with Therapeutic Effects in Mouse Models of Social Interaction and Cognitive Impairment.

Jianhang Mao, Yilong Cui, Huan Wang

|Jun 05, 2023
Adenosine A

Jinfeng Zhang, Dandan Feng, Jianjun Cheng

|May 02, 2023
Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents.

Ruiquan Liu, Jianzhong Qi, Huan Wang

Pageof 4

Frequent Collaborators

5 joint publications

Sheng Wang

4 joint publications

Suwen Zhao

3 joint publications

Dong Guo

2 joint publications

Tian Hua